LongeVC — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Valink Therapeuticsvalinktx.cominOct 2025
Valink Therapeutics develops bispecific antibody-drug conjugates (ADCs) for therapeutic applications, combining high-throughput discovery, antibody engineering, and medicinal chemistry capabilities.
AI & Machine LearningBiotechHealthtechMedical DevicesBoston, US
Arne Scheu(Founder)inIrsyad Khairil(Founder)in
Co-investorsHoxton VenturesMetaplanetOxonian VenturesP53 InvestSynBioVenY Combinator+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.